| scholarly article | Q13442814 |
| P2093 | author name string | H L Ozer | |
| K K Jha | |||
| J J Dermody | |||
| D R Chowdary | |||
| P2860 | cites work | Wild-type p53 binds to the TATA-binding protein and represses transcription | Q24300991 |
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| UBA 1: an essential yeast gene encoding ubiquitin-activating enzyme | Q27931184 | ||
| The yeast cell cycle gene CDC34 encodes a ubiquitin-conjugating enzyme | Q27933363 | ||
| The Pas2 protein essential for peroxisome biogenesis is related to ubiquitin-conjugating enzymes | Q27935511 | ||
| Cyclin is degraded by the ubiquitin pathway | Q28131704 | ||
| Amplification of a gene encoding a p53-associated protein in human sarcomas | Q28270924 | ||
| The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
| Identification of p53 as a sequence-specific DNA-binding protein | Q28282745 | ||
| Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis | Q29547538 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
| Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter | Q29614259 | ||
| The ubiquitin system for protein degradation | Q29614385 | ||
| Suppression of human colorectal carcinoma cell growth by wild-type p53 | Q29618318 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| Wild-type p53 can inhibit oncogene-mediated focus formation | Q30450825 | ||
| Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. | Q33513306 | ||
| Molecular cloning, primary structure and expression of the human X linked A1S9 gene cDNA which complements the ts A1S9 mouse L cell defect in DNA replication | Q33921464 | ||
| Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest | Q33937821 | ||
| Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
| Monoclonal antibodies specific for simian virus 40 tumor antigens | Q34249232 | ||
| The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
| Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase | Q35340408 | ||
| Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells | Q35476763 | ||
| p53 function and dysfunction | Q35721291 | ||
| Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line | Q35926080 | ||
| Retinoblastoma protein and simian virus 40-dependent immortalization of human fibroblasts | Q36692841 | ||
| Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen | Q36793131 | ||
| The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40. | Q36827839 | ||
| The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. | Q36828715 | ||
| Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines | Q36919740 | ||
| Energy Requirement for Degradation of Tumor-Associated Protein p53 | Q36941962 | ||
| Characterization of a ts mutant of BALB/3T3 cells and correction of the defect by in vitro addition of extracts from wild-type cells | Q36947586 | ||
| Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells | Q36966578 | ||
| Degradation of nuclear oncoproteins by the ubiquitin system in vitro | Q37361143 | ||
| p53 mutations: gains or losses? | Q37669027 | ||
| The p53 tumour suppressor gene | Q37751892 | ||
| Regulation of the specific DNA binding function of p53 | Q38324290 | ||
| Temperature-sensitive mutants of Balb/3T3 cells: Description of a mutant affected in cellular and polyoma virus DNA synthesis | Q40006849 | ||
| Monoclonal antibody analysis of p53 expression in normal and transformed cells | Q40127251 | ||
| A transcriptionally active DNA-binding site for human p53 protein complexes | Q40655196 | ||
| Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form | Q41210647 | ||
| Temperature-sensitive mutants of BALB/3T3 cells. III. Hybrids between ts2 and other mouse mutant cells affected in DNA synthesis and correction of ts2 defect by human X chromosome | Q42828142 | ||
| Specific interaction between the p53 cellular tumour antigen and major heat shock proteins | Q43512047 | ||
| Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription | Q44511165 | ||
| Restriction of human adenovirus replication in Chinese hamster cell lines and their hybrids with human cells | Q44672534 | ||
| A site-directed approach for constructing temperature-sensitive ubiquitin-conjugating enzymes reveals a cell cycle function and growth function for RAD6 | Q44687600 | ||
| Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication | Q44703400 | ||
| Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. | Q44769248 | ||
| Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. | Q53505779 | ||
| Mutant p53 proteins bind hsp 72/73 cellular heat shock-related proteins in SV40-transformed monkey cells. | Q53529837 | ||
| Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135. | Q53965077 | ||
| Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. | Q54451283 | ||
| Regulation of the human hsp70 promoter by p53 | Q64377885 | ||
| Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells | Q64381309 | ||
| Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3' end of SV40 gene A | Q69815443 | ||
| Differential replication of SV40 and polyoma DNAs in Chinese hamster ovary cells | Q70099048 | ||
| P4510 | describes a project that uses | BALB/3T3 clone A31 ts20 | Q54606748 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 1997-2003 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway | |
| P478 | volume | 14 |
| Q73270737 | 2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression |
| Q28384242 | 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal |
| Q24317155 | A human ubiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's disease locus on chromosome 14q24.3 |
| Q28305429 | A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 |
| Q24328749 | A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2 |
| Q28289710 | A novel DNA damage response: rapid degradation of the p12 subunit of dna polymerase delta |
| Q33957786 | A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation |
| Q36144840 | A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. |
| Q38614411 | A ubiquitin-conjugating enzyme is essential for developmental transitions in Dictyostelium |
| Q40085549 | Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications |
| Q58376437 | Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome |
| Q42797525 | An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. |
| Q24522556 | An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells |
| Q40230307 | Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway |
| Q33654858 | Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? |
| Q34410831 | Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase |
| Q24312018 | Binding and modulation of p53 by p300/CBP coactivators |
| Q40234235 | Biosynthesis of the β-Lactone Proteasome Inhibitors Belactosin and Cystargolide. |
| Q36413446 | CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination |
| Q33506801 | Calcium-dependent plasma membrane repair requires m- or mu-calpain, but not calpain-3, the proteasome, or caspases |
| Q52166635 | Cell-cycle control in cell-biomaterial interactions: expression of p53 and Ki67 in human umbilical vein endothelial cells in direct contact and extract testing of biomaterials. |
| Q36498260 | Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step |
| Q40491044 | Cellular ubiquitination and proteasomal functions positively modulate mammalian nucleotide excision repair |
| Q40893338 | Characterization of the mouse JAB1 cDNA and protein |
| Q33578136 | Characterization of ubiquitin-activating enzyme Uba1 in the nucleus by its mammalian temperature-sensitive mutant |
| Q42005935 | Chronology of p53 protein accumulation in gastric carcinogenesis |
| Q22253965 | Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18) |
| Q41455294 | Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system |
| Q41535643 | Complex mechanisms for c-fos and c-jun degradation |
| Q24594232 | Condensation by DNA looping facilitates transfer of large DNA molecules into mammalian cells |
| Q40916028 | Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects. |
| Q41066929 | Control of gene expression by proteolysis |
| Q37365357 | Correcting temperature-sensitive protein folding defects |
| Q43628877 | Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway |
| Q34945470 | Cytomegalovirus downregulates IRE1 to repress the unfolded protein response |
| Q37088586 | Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide |
| Q41121273 | Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells |
| Q41989142 | DNA cleavage and Trp53 differentially affect SINE transcription |
| Q24813820 | DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation |
| Q28592240 | DUB-1, a deubiquitinating enzyme with growth-suppressing activity |
| Q40502823 | Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme |
| Q34214151 | Degradation of cellular and viral Fos proteins |
| Q36556567 | Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes |
| Q33890400 | Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. |
| Q33997846 | Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress |
| Q35040985 | Distant positioning of proteasomal proteolysis relative to actively transcribed genes |
| Q43624992 | Downregulation of free ubiquitin: a novel mechanism of p53 stabilization and neuronal cell death |
| Q58694254 | Dynamic regulation of dynein localization revealed by small molecule inhibitors of ubiquitination enzymes |
| Q28273896 | Effects of histone deacetylase inhibitors on HIF-1 |
| Q37357390 | Endoplasmic reticulum stress-induced cell death mediated by the proteasome |
| Q24300071 | FAT10, a ubiquitin-independent signal for proteasomal degradation |
| Q34164614 | From p63 to p53 across p73. |
| Q35106399 | Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis |
| Q42812297 | Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway |
| Q77845951 | Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway |
| Q39875158 | High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. |
| Q34519869 | Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha |
| Q40211366 | Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). |
| Q40120827 | Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. |
| Q36310068 | Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins |
| Q37142785 | Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination |
| Q33558621 | Human cytomegalovirus gene UL21a encodes a short-lived cytoplasmic protein and facilitates virus replication in fibroblasts |
| Q40922670 | Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light |
| Q37371723 | Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. |
| Q24321129 | Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53 |
| Q44468579 | Identification of a region of p53 that confers lability |
| Q33278919 | Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas |
| Q36565973 | Incubation at the nonpermissive temperature induces deficiencies in UV resistance and mutagenesis in mouse mutant cells expressing a temperature-sensitive ubiquitin-activating enzyme (E1) |
| Q39681563 | Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1 |
| Q59127567 | Infection with flaviviruses requires BCLXL for cell survival |
| Q33936687 | Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. |
| Q78171317 | Inhibition of RNA polymerase II as a trigger for the p53 response |
| Q40971472 | Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation |
| Q40021229 | Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication |
| Q37343953 | Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium |
| Q34191852 | Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. |
| Q47955822 | Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase |
| Q73320007 | Mechanism of p53 degradation |
| Q36661538 | Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation |
| Q40460116 | Molecular Events in Thymocyte Apoptosis |
| Q40874935 | Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo |
| Q34248458 | Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation |
| Q42831717 | Murine cytomegalovirus US22 protein pM140 protects its binding partner, pM141, from proteasome-dependent but ubiquitin-independent degradation |
| Q36201740 | Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. |
| Q24563960 | N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome |
| Q44255815 | Negative feedback regulation of Aurora-A via phosphorylation of Fas-associated factor-1. |
| Q53427647 | No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. |
| Q28205086 | Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2 |
| Q50268944 | Nuclear localization of ubiquitin-activating enzyme Uba1 is characterized in its mammalian temperature-sensitive mutant. |
| Q28609844 | Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2 |
| Q73240740 | On the involvement of calpains in the degradation of the tumor suppressor protein p53 |
| Q34390794 | P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1 |
| Q24301769 | Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD |
| Q39227140 | Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63. |
| Q39763520 | Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. |
| Q41535647 | Prosomes (proteasomes) changes during differentiation are related to the type of inducer |
| Q34281710 | Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. |
| Q40115653 | Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells |
| Q34868376 | Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein |
| Q27932737 | Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination |
| Q42824507 | Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction |
| Q36568304 | Proteolysis by calpains: a possible contribution to degradation of p53. |
| Q36564973 | Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability |
| Q24683060 | Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation |
| Q28261724 | Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron |
| Q41459265 | Regulating protein degradation by ubiquitination |
| Q24323315 | Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors |
| Q24610199 | Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha |
| Q34407948 | Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death |
| Q35531278 | Replication of the rotavirus genome requires an active ubiquitin-proteasome system |
| Q24336020 | Repression of p53-mediated transcription by MDM2: a dual mechanism |
| Q34288454 | SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. |
| Q36298444 | Serine 123 phosphorylation modulates p21 protein stability and activity by suppressing ubiquitin-independent proteasomal degradation |
| Q41829477 | Stability of the endosomal scaffold protein LAMTOR3 depends on heterodimer assembly and proteasomal degradation. |
| Q35912100 | Stabilization and activation of p53 are regulated independently by different phosphorylation events |
| Q41020740 | Stabilization of p53 by adenovirus E1A occurs through its amino-terminal region by modification of the ubiquitin-proteasome pathway |
| Q41725526 | Strategies for correcting the delta F508 CFTR protein-folding defect |
| Q27676781 | Structural and Molecular Characterization of Iron-sensing Hemerythrin-like Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5) |
| Q42680947 | Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. |
| Q34926147 | TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation |
| Q38996247 | Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity |
| Q42703666 | The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner |
| Q40837805 | The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism |
| Q47072545 | The DUG gene of Drosophila melanogaster encodes a structural and functional homolog of the S. cerevisiae SUG1 predicted ATPase associated with the 26S proteasome. |
| Q35851139 | The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors |
| Q36573999 | The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1 |
| Q73787111 | The contribution of the acidic domain of MDM2 to p53 and MDM2 stability |
| Q24291244 | The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation |
| Q33633763 | The hydrophobic patch of ubiquitin is required to protect transactivator-promoter complexes from destabilization by the proteasomal ATPases |
| Q35036580 | The p53-Mdm2 module and the ubiquitin system. |
| Q41193565 | The role of DNA repair in the prevention of cancer |
| Q40930060 | The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited |
| Q73171130 | The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association |
| Q41370400 | The ubiquitin system: a role in disease? |
| Q36295120 | The ubiquitin-proteasome pathway in cancer |
| Q29618638 | The ubiquitin-proteasome proteolytic pathway |
| Q33965851 | Tumor suppressor p53 is required to modulate BRCA1 expression |
| Q35250252 | Two mutations impair the stability and function of ubiquitin-activating enzyme (E1) |
| Q40262460 | UV Induces p21 rapid turnover independently of ubiquitin and Skp2. |
| Q39969912 | UVB-induced murine bone marrow derived macrophages and apoptosis |
| Q40456510 | Ubiquitin and the Enigma of Intracellular Protein Degradation |
| Q34446282 | Ubiquitin proteasome pathway: implications and advances in cancer therapy |
| Q35880075 | Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion |
| Q39715640 | Ubiquitin-independent degradation of antiapoptotic MCL-1. |
| Q37343693 | Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. |
| Q27481222 | Ubiquitination and proteasomal degradation of interferon regulatory factor-3 induced by Npro from a cytopathic bovine viral diarrhea virus |
| Q24292946 | Ubiquitination regulates PTEN nuclear import and tumor suppression |
| Q36059498 | Ubiquitylation-independent degradation of Xeroderma pigmentosum group C protein is required for efficient nucleotide excision repair |
| Q40812884 | Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade |
| Q38319447 | Zebrafish id2 developmental expression pattern contains evolutionary conserved and species-specific characteristics |
| Q42576383 | c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics |
| Q36573568 | c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition |
| Q38294077 | p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches |
| Q33632282 | p53 and the CNS: tumors and developmental abnormalities |
| Q45947669 | p53 point mutation is rare in meningiomas from Singaporean patients. |
| Q36618282 | p53 status of newly established acute myeloid leukaemia cell lines |
| Q41715281 | p53--an acrobat in tumorigenesis |
| Q35718450 | p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. |
| Q37297319 | p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts |
Search more.